Estimated Net Promoter Score is
Ionis Pharmaceuticals is a publicly traded pharmaceutical company based in Carlsbad, California, United States. The company was founded in 1989 by Stanley Crooke, a former GlaxoSmithKline head of research, with a goal to commercialize antisense therapy.
The company received its first FDA approval for an investigational new drug application in 1992, marking the first time any antisense drug was approved to be tested in humans; the IND was for Isis' genital warts drug candidate.
The company and others founded to bring antisense drugs to market faced early failures; Isis' lead compound for genital warts failed in clinical trials and Isis terminated development in 1995; by that time two other companies working on antisense, Gilead Sciences and Genta had left the field, leaving Isis, Hybridon, and Lynx Therapeutics working in the field. Gilead sold the patents it had developed around antisense to Isis.
In December 2015 Isis changed its name to Ionis, driven in part by the negative image of "Isis" generated by the terrorist group, Islamic State of Iraq and the Levant, commonly known as ISIL or ISIS.
NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.
It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.
The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.
Yes, it is.
Net Promoter Score is a number from -100 from 100.
Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.
The industry average for Health Care / Major Pharmaceuticals is 0.
The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.
Consider an example: If Ionis Pharmaceuticals, Inc. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.
On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.
Therefore, comparing the NPS score of Ionis Pharmaceuticals, Inc. with your own without any further context is not that useful.
What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.
After successfully using Net Promoter Score for our own e-commerce projects, we have decided to let anyone benefit from what we've learned.
We have founded Customer.guru in 2016 to help e-shops, SaaS services and startups better understand their customers, improve their services and increase their revenues.
Customer.guru is an easy-to-setup tool for tracking segmented customer satisfaction using Net Promoter Score.
|Discovery Channel||Consumer Brands / Entertainment||4|
|Super 8||Travel and Hospitality / Hotels||4|
|U.S. Bank||Financial Services / Banking||3|
|NatWest Personal Banking||Financial Services / Banking||5|
|Sprint||Telecommunications / Wireless Carrier||5|
|EE||Telecommunications / Wireless Carrier||5|
|Goldman Sachs||Financial Services / Banking||5|
|Freeview||Telecommunications / Cable/TV service||5|
|Mastercard||Financial Services / Credit cards||5|
We have estimated the Net Promoter Score of Ionis Pharmaceuticals, Inc. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.